reference/32218340

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32218340

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	346
issn	1465-3621 0368-2811
issueIdentifier	5
pageRange	339-346
publicationName	Japanese Journal of Clinical Oncology
startingPage	339
bibliographicCitation	Nakagawa K, Yamazaki K, Kunitoh H, Hida T, Gemba K, Shinkai T, Ichinose Y, Adachi S, Nambu Y, Saijo N, Fukuoka M. Efficacy and Safety of Pemetrexed in Combination with Cisplatin for Malignant Pleural Mesothelioma: A Phase I/II Study in Japanese Patients. Japanese Journal of Clinical Oncology. 2008 Apr 22;38(5):339–46. doi: 10.1093/jjco/hyn024.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52d100808d98835f53138cb04fe549fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49d8c0e89fcf913eefbdea95fa567603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a4b901e4b29a83ece0cca59d7bd341e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd85236c7bd1ea756a279fd830c9758a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e66b40e9b75e762204300bc3ad403dfd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30de5c58e7e29d00d6eb9e285102f8d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_859bc11480788496e6c552dec98a9030 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b96cbb8b6b86202e0e7d3c8b88f31ff3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efd90b919df1d81d48c3793b6da82a07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84f66cbdc127914b62dcbb3a4b67401f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_412a1cae4b39e400a07800627c7ba4c9
date	2008-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18434338 https://doi.org/10.1093/jjco/hyn024
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5361 https://portal.issn.org/resource/ISSN/0368-2811 https://portal.issn.org/resource/ISSN/1465-3621
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of Pemetrexed in Combination with Cisplatin for Malignant Pleural Mesothelioma: A Phase I/II Study in Japanese Patients
discusses	http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0008662 http://id.nlm.nih.gov/mesh/M0227083
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008654Q000188 http://id.nlm.nih.gov/mesh/D010997Q000188 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D000964Q000008 http://id.nlm.nih.gov/mesh/D012129 http://id.nlm.nih.gov/mesh/D002945Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D005493Q000008 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D010997Q000503 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005493Q000009 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D000964Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008654Q000503 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D007564 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6761 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837

Total number of triples: 77.